ARTV

Quote

Short

News

Articles

Message Board

Artiva Biotherapeutics Inc. (NASDAQ : ARTV ) News

News Releases

ARTV News Releases

July 17, 2026 07:30:00 am

GlobeNewswire

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 23, 2026 04:05:00 pm

GlobeNewswire

Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

June 08, 2026 06:30:00 am

GlobeNewswire

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

May 29, 2026 09:00:00 am

Canada Newswire

The $13 Million Company Teaching the Immune System to Hunt Cancer

May 28, 2026 08:00:00 am

GlobeNewswire

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 26, 2026 08:15:06 am

KlickAnalytics

Overweight Recommendation Issued On ARTV By Cantor Fitzgerald

May 19, 2026 04:05:00 pm

GlobeNewswire

Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases

May 19, 2026 08:00:00 am

GlobeNewswire

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

May 14, 2026 12:45:00 pm

Baystreet

First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid Tumors

May 14, 2026 09:00:39 am

Financial News Media

Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account